OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 71 filers reported holding OCULAR THERAPEUTIX INC in Q3 2015. The put-call ratio across all filers is 1.76 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $733 | +19.4% | 233,582 | +96.4% | 0.06% | +3.3% |
| Q2 2023 | $614 | -99.9% | 118,953 | -7.1% | 0.06% | -20.8% |
| Q2 2022 | $514,000 | +80.4% | 127,978 | +122.1% | 0.08% | +102.6% |
| Q1 2022 | $285,000 | +738.2% | 57,620 | +413.5% | 0.04% | +660.0% |
| Q3 2019 | $34,000 | -66.7% | 11,222 | -28.1% | 0.01% | 0.0% |
| Q1 2018 | $102,000 | -60.9% | 15,600 | +25.7% | 0.01% | -50.0% |
| Q2 2015 | $261,000 | – | 12,412 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |